Dolby Laboratories, Inc. (DLB)

Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 27, 2024	Sep 27, 2024	Sep 29, 2023	Sep 30, 2022	Sep 24, 2021	Sep 25, 2020
Cash & Equivalents	520.82	482.05	745.36	620.13	1,225	1,072
Short-Term Investments	-	-	139.15	189.21	38.84	46.95
Cash & Short-Term Investments	520.82	482.05	884.51	809.34	1,264	1,119
Cash Growth	-34.71%	-45.50%	9.29%	-35.98%	13.00%	22.10%
Accounts Receivable	560.2	512.94	444.38	419.69	414.93	341.7
Receivables	560.2	512.94	444.38	419.69	414.93	341.7
Inventory	31.83	33.73	35.62	23.55	10.97	25.55
Prepaid Expenses	32.04	29.75	24.44	26.85	29.96	17.88
Restricted Cash	90.84	95.71	72.6	8.24	7.65	8.1
Other Current Assets	50.07	40.25	26.26	23.22	32.77	35.14
Total Current Assets	1,286	1,194	1,488	1,311	1,760	1,547
Property, Plant & Equipment	513.09	518.16	521.78	560.01	601.51	618.48
Long-Term Investments	86.3	89.27	97.81	102.51	62.82	52.15
Goodwill	520.42	533.21	408.41	365.15	340.69	336.95
Other Intangible Assets	421.24	434.51	167.43	112.27	122.89	152.43
Long-Term Deferred Tax Assets	227.02	219.76	201.86	183.57	156.02	118.88
Other Long-Term Assets	104.73	120.61	94.67	55.15	61.26	91.25
Total Assets	3,159	3,110	2,980	2,690	3,106	2,917
Accounts Payable	11.55	17.38	20.93	14.17	17.78	12.62
Accrued Expenses	151.05	171.01	179.01	143.15	157.69	134.31
Current Portion of Leases	11.43	12.24	13.63	13.26	15.4	15.82
Current Income Taxes Payable	20.88	9.05	4.77	1.27	1.33	3.26
Current Unearned Revenue	37.11	31.64	31.51	18.59	18.47	15.44
Other Current Liabilities	209.87	176.52	172.39	87.09	105.03	85.66
Total Current Liabilities	441.88	417.84	422.23	277.52	315.72	267.11
Long-Term Leases	33.02	34.75	37.02	37.69	56.72	65.32
Long-Term Unearned Revenue	32.48	34.59	40	23.2	23.71	24.34
Other Long-Term Liabilities	128.98	130.91	104.04	96	100.43	117.97
Total Liabilities	641.57	623.04	607.58	438.53	501.46	478.92
Common Stock	0.1	0.09	0.09	0.09	0.1	0.1
Retained Earnings	2,543	2,496	2,392	2,298	2,608	2,443
Comprehensive Income & Other	-35.54	-19.19	-36.98	-51.64	-10.03	-10.59
Total Common Equity	2,508	2,477	2,355	2,246	2,598	2,433
Minority Interest	9.06	9.73	17.08	4.84	6.25	5.76
Shareholders' Equity	2,517	2,487	2,372	2,251	2,604	2,438
Total Liabilities & Equity	3,159	3,110	2,980	2,690	3,106	2,917
Total Debt	44.45	46.99	50.65	50.94	72.12	81.14
Net Cash (Debt)	476.38	435.06	833.86	758.4	1,192	1,038
Net Cash Growth	-36.52%	-47.83%	9.95%	-36.38%	14.88%	13.24%
Net Cash Per Share	4.90	4.47	8.53	7.44	11.39	10.08
Filing Date Shares Outstanding	96.38	95.44	95.28	95.96	101.16	100.35
Total Common Shares Outstanding	96.36	95.39	95.76	95.88	101.07	100.3
Working Capital	843.92	776.58	1,066	1,033	1,445	1,280
Book Value Per Share	26.03	25.97	24.59	23.43	25.70	24.25
Tangible Book Value	1,566	1,509	1,779	1,769	2,134	1,943
Tangible Book Value Per Share	16.25	15.82	18.58	18.45	21.12	19.38
Land	41.94	42.01	41.9	41.77	42.04	41.96
Buildings	290.23	288.91	287.8	287.54	284.15	283.62
Machinery	428.66	410.94	418.53	402.9	420.55	389.59
Construction In Progress	25.68	25.09	18.33	23.04	22.92	19.55
Leasehold Improvements	84.23	86.61	79.99	86.79	88.55	83.76

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q